Back to top

Image: Bigstock

Zacks Investment Ideas feature highlights: Kroger, General Mills and Johnson & Johnson

Read MoreHide Full Article

For Immediate Release

Chicago, IL – October 10, 2022 – Today, Zacks Investment Ideas feature highlights The Kroger Co. (KR - Free Report) , General Mills (GIS - Free Report) and Johnson & Johnson (JNJ - Free Report) .

Sail Through Rough Waters with These 3 Low-Beta Stocks

When looking for safe places to park cash during heightened volatility, targeting low-beta stocks is an excellent strategy that investors can deploy.

Beta is a measure of a stock's systematic risk, or volatility, compared to the market as a whole. Generally, the benchmark is the S&P 500, which has a beta of 1.0.

Stocks with a beta higher than 1.0 are more sensitive to the market’s movements, while those with a beta less than 1.0 are less susceptible.

For those seeking shelter from volatility, three stocks – The Kroger Co., General Mills and Johnson & Johnson – would be great places to start.

On top of carrying a beta of less than 1.0, all three have rock-solid dividend metrics, a significant positive that helps alleviate drawdowns in other positions.

All three have widely outperformed the general market in 2022, indicating that buyers have defended the stocks at a much higher level than most.

Let’s take a deeper look at each one.

General Mills

General Mills is a global manufacturer and marketer of branded consumer foods sold through retail stores. We see their products on nearly every shelf.

GIS carries a beta of 0.32.

The company has witnessed positive earnings estimate revisions as of late, helping push the company into a favorable Zacks Rank #2 (Buy).

For those seeking an income stream, General Mills has that covered; the company’s annual dividend yields a rock-solid 2.8% paired with a payout ratio sitting at 53% of earnings.

The company’s annual dividend yield is just a tick below the Zacks Consumer Discretionary sector average of 2.9%.

Further, GIS is forecasted to grow at an inspiring pace – earnings are forecasted to grow 3.6% in FY23 and a further 6.6% in FY24.

The earnings growth comes on top of forecasted revenue increases of 2.8% and 2.2% for FY23 and FY24, respectively.

Johnson & Johnson

Headquartered in New Jersey, Johnson & Johnson is an American multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods.

JNJ carries a beta of 0.56.

Johnson & Johnson has been heavily dedicated to rewarding its shareholders; the company is a member of the elite Dividend King club, upping its dividend payout for a mind-boggling 60 consecutive years.

The company’s annual dividend yields a sizable 2.8%, notably higher than its Zacks Medical sector average of 1.5%.

JNJ has an impressive earnings track record – the company hasn’t reported earnings below the Zacks Consensus EPS Estimate dating all the way back to 2012. Just in its latest print, JNJ penciled in a marginal 0.8% bottom line beat.

Sales results have also been commendable, with JNJ exceeding revenue estimates in seven of its last ten quarterly reports.

In addition, JNJ shares appear reasonably priced, further bolstered by its Style Score of a B for Value.

Shares trade at a 16.0X forward earnings multiple, a few notches below their five-year median of 16.8X and representing a sizable 24% discount relative to their Zacks Medical sector.

The Kroger Co.

Founded in 1883, the long-time retailer operates approximately 2,700 retail stores under various banners and divisions in 35 states.

KR has a beta of 0.51.

Like General Mills, analysts have been bullish on Kroger’s near-term earnings outlook over the last several months, helping land the stock into a Zacks Rank #2 (Buy).

KR shares are cheap; the company’s 10.8X forward earnings multiple is nicely below its 12.6X five-year median and reflects a steep 55% discount relative to its Zacks Retail and Wholesale sector average.

For the cherry on top, KR rewards its shareholders via its annual dividend that yields a respectable 2.4%, notably higher than its Zacks Sector average of 1%.  

KR’s dividend growth is even more impressive – the company has upped its dividend payout five times over the last five years, paired with a double-digit 13.2% five-year annualized dividend growth rate.

Bottom Line

With the market sailing through a historically-volatile year, it goes without saying that adding some defensive stocks would benefit investors.

Low-beta stocks are a great way to shield yourself against volatility, as they are less susceptible to the market’s moves.

Of course, some gains could be missed, but defense wins ballgames.

For those searching for low-beta stocks with solid dividend payouts, all three stocks deserve consideration. 

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Johnson & Johnson (JNJ) - free report >>

General Mills, Inc. (GIS) - free report >>

The Kroger Co. (KR) - free report >>

Published in